Emerging Biomarkers of Response to Systemic Therapies in Metastatic Clear Cell Renal Cell Carcinoma

被引：4
|
作者：
Labaki, Chris [1 ,2 ]
Saliby, Renee Maria [1 ]
Bakouny, Ziad [1 ,3 ]
Saad, Eddy [1 ]
Semaan, Karl [1 ]
Eid, Marc [1 ]
Lalani, Aly-Khan [4 ]
Choueiri, Toni K. [1 ]
Braun, David A. [5 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Med, Boston, MA USA
[4] McMaster Univ, Juravinski Canc Ctr, Hamilton, ON, Canada
[5] Yale Sch Med, Ctr Mol & Cellular Oncol CMCO, New Haven, CT USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 05期
关键词：
Renal cell carcinoma; Biomarkers; Systemic therapy; Immunotherapy; Targeted therapy; MOLECULAR SUBTYPES; 1ST-LINE TREATMENT; CHECKPOINT; SUNITINIB;
D O I：
10.1016/j.hoc.2023.05.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：937 / 942
页数：6
相关论文
共 50 条
  • [1] Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma
    Atkins, Michael B.
    Tannir, Nizar M.
    CANCER TREATMENT REVIEWS, 2018, 70 : 127 - 137
  • [2] Metastatic clear cell renal cell carcinoma: Circulating biomarkers to guide antiangiogenic and immune therapies
    Zhang, Tian
    Zhu, Jason
    George, Daniel J.
    Nixon, Andrew B.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (11) : 510 - 518
  • [3] Current and emerging therapies for first line treatment of metastatic clear cell renal cell carcinoma
    Serzan, Michael T.
    Atkins, Michael B.
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2021, 7
  • [4] Current and emerging first-line systemic therapies in metastatic clear-cell renal cell carcinoma
    Tegos, Theodoros
    Tegos, Konstantinos
    Dimitriadou, Areti
    Dimitriadis, Georgios
    JOURNAL OF BUON, 2019, 24 (04): : 1340 - 1353
  • [5] Update on systemic therapies of metastatic renal cell carcinoma
    Herrmann, E.
    Bierer, S.
    Wuelfing, C.
    WORLD JOURNAL OF UROLOGY, 2010, 28 (03) : 303 - 309
  • [6] Innovative Therapies Targeting Drug-Resistant Biomarkers in Metastatic Clear Cell Renal Cell Carcinoma (ccRCC)
    Abah, Moses Owoicho
    Ogenyi, Deborah Oganya
    Zhilenkova, Angelina V.
    Essogmo, Freddy Elad
    Tchawe, Yvan Sinclair Ngaha
    Uchendu, Ikenna Kingsley
    Pascal, Akaye Madu
    Nikitina, Natalia M.
    Rusanov, Alexander S.
    Sanikovich, Varvara D.
    Pirogova, Yuliya N.
    Boroda, Alexander
    Moiseeva, Aleksandra V.
    Sekacheva, Marina I.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (01)
  • [7] A critical appraisal of systemic treatment options for metastatic non-clear cell renal cell carcinoma
    Ismail, Salima
    Meskawi, Malek
    Hansen, Jens
    Bianchi, Marco
    Tian, Zhe
    Latour, Mathieu
    Graefen, Markus
    Montorsi, Francesco
    Quoc-Dien Trinh
    Perrotte, Paul
    Karakiewicz, Pierre I.
    Sun, Maxine
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2014, 90 (01) : 49 - 57
  • [8] Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma
    Nerich, Virginie
    Hugues, Marion
    Paillard, Marie Justine
    Borowski, Laetitia
    Nai, Thierry
    Stein, Ulrich
    Hon, Thierry Nguyen Tan
    Montcuquet, Philippe
    Maurina, Tristan
    Mouillet, Guillaume
    Kleinclauss, Francois
    Pivot, Xavier
    Limat, Samuel
    Thiery-Vuillemin, Antoine
    ONCOTARGETS AND THERAPY, 2014, 7 : 365 - 374
  • [9] Combination drug regimens for metastatic clear cell renal cell carcinoma
    Khetani, Viraj V.
    Portal, Daniella E.
    Shah, Mansi R.
    Mayer, Tina
    Singer, Eric A.
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2020, 11 (08):
  • [10] Systemic Therapy for Metastatic Renal Cell Carcinoma
    Kramer, M. W.
    Steffens, S.
    von Klot, C.
    Merseburger, A. S.
    Kuczyk, M. A.
    AKTUELLE UROLOGIE, 2012, 43 (04) : 265 - 268
12345